Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea · Delayed Price · Currency is KRW 1,891.00
-75.00 (-3.81%)
At close: Oct 22, 2026
Kangstem Biotech Market Cap
Kangstem Biotech has a market cap or net worth of 177.86 billion as of October 22, 2026. It is the 23,037th most valuable company in the world and the 890th biggest in South Korea. Its market cap has increased by 34.21% in one year.
Market Cap
177.86B
Enterprise Value
159.63B
Revenue
3.03B
Global Rank
Country Rank
#890 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 21, 2015, Kangstem Biotech's market cap has increased from 129.33B to 177.86B, an increase of 37.52%. That is a compound annual growth rate of 2.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 177.86B | -18.49% |
| Dec 30, 2025 | 218.21B | 92.71% |
| Dec 30, 2024 | 113.23B | -15.48% |
| Dec 28, 2023 | 133.97B | 21.98% |
| Dec 29, 2022 | 109.83B | -11.47% |
| Dec 30, 2021 | 124.06B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| S.Biomedics | 262.56B |
| IntoCell | 249.51B |
| IMBiologics | 221.06B |
| Genome & Company | 220.70B |
| curacle co.,ltd. | 201.63B |
| NIBEC | 177.46B |
| ISU Abxis | 153.52B |
| Bio Solution | 151.99B |